Introducing the new AltIndexLearn more
$1.881.6%downside
Price 6 Months Forecast & Ratings · Updated Aug 18, 2026
47/100 AI Score
Neutral
Brand
0/100
Employment
0/100
User Growth
0/100
Fundamental
17/100
Get DRRX AI Score alerts →

DURECT (DRRX) Price Target: AI vs Analyst Consensus

Our AI model gives DURECT (DRRX) a 6-month price target of $1.88, representing 1.6% potential downside from the current price of $1.91. The forecast combines financial fundamentals, technical analysis, and 25+ alternative data signals, including hiring trends, web traffic, employee sentiment, and social media activity. DURECT’s current AI Score is 47/100 (Neutral).

What’s Driving the DRRX Price Target

These are the signals feeding DURECT’s AI price target — spanning financial fundamentals, technical analysis, and alternative data — grouped by their recent direction. Improving signals tend to support a higher target; declining signals weigh on it.

Signals trending up

No signals trending up right now.

Signals trending down
Quarterly revenue

DRRX Stock Forecast for 2026

Our AI model gives DURECT (DRRX) a 6-month price target of $1.88 — 1.6% downside from the current price of $1.91 — implying a decline toward that level through the rest of 2026. The target updates daily as new DRRX financial, technical, and alternative-data signals come in.

DRRX Price Prediction for 2027–2030

AltIndex does not publish a multi-year model — alternative data is most predictive over the next 6–12 months. Extending the current trajectory as a simple linear extrapolation projects DRRX toward $1.71 by 2030, but long-range estimates carry far more uncertainty and should be treated as directional only. The more reliable signal is whether DURECT’s AI Score and the drivers above keep improving over time.

DURECT (DRRX) Monthly Price Forecast

MonthForecastvs Current
Sep 2026 $1.91 -0.3%
Oct 2026 $1.90 -0.5%
Nov 2026 $1.90 -0.8%
Dec 2026 $1.89 -1%
Jan 2027 $1.89 -1.3%
Feb 2027 $1.88 -1.6%

Straight-line projection from the latest price ($1.91) toward our 6-month AI target of $1.88. An estimate, not a month-by-month model.

See how AltIndex’s AI Score picks have performed →

Frequently Asked Questions: DURECT Price Prediction

On August 16, DURECT (DRRX) was assigned a Hold with a target price of $1.88. This signal was predicated on several factors, including several proprietary signals.
The conviction in the pick is low due to the limited amount of alternative data available.

Based on Alternative Data, DURECT is a hold.

Alternative data suggests that it's recommended to approach DURECT (DRRX) with caution. While there are positive indicators, the overall assessment suggests a hold based on Alternative Data analysis. However, this information should not be considered financial advice.

With an AI score of 47, the DRRX stock forecast suggests stability.

To predict the price for DRRX in 2027, we can extrapolate the AI price target. This approach projects DRRX's price to reach $1.89.

To predict the price for DRRX in 2030, we can again extrapolate the AI price target. This approach projects DRRX's price to reach $1.71.

When predicting the price for DRRX, our approach incorporates multiple scores assessing different aspects of the company. The Brand score measures growth and engagement across social media channels, indicating audience reach. The Employee score evaluates workforce health, considering job postings, business outlook, and employee ratings. The Customer score examines engagement on websites, app downloads, and sentiment in stock forums. Lastly, the Fundamental score analyzes financial statements and analyst ratings. By evaluating this data, we gain a holistic view of the company's performance, enabling more informed price predictions.

Based on technical analysis of how the price has moved over the last 6 months is hard to tell since there has been no significant change in the price today to base a prediction on. Note that this is a simplistic analysis and should be used with caution, as prices are influenced by a myriad of factors.

Know the moment DURECT’s price target changes

Get DRRX alerts
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.